VC
Vivo Capital
Venture CapitalActiveVivo Capital is a global investment firm focused on healthcare.
121
Investments
53
Exits
$717M
AUM
43.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Vivo Capital.
Investment Thesis & Strategy
Vivo Capital invests in healthcare companies across various stages, seeking to support innovative solutions and drive growth within the global healthcare landscape.
Investment Activity
Deals per year over the last 11 years
1
20110
20121
20133
20141
20152
20162
20171
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 121 companies
W
Wugen
Biotech · Series B, 2021
J
JA Biotech
Biotech · Growth, 2018
G
Gossamer Bio
Biotech · Series A, 2017
T
Turning Point Therapeutics
Biotech · Growth, 2017
H
Harbour BioMed
Biotech · Growth, 2016
A
Apollomics
Biotech · Growth, 2016
I
I-Mab
Biotech · Growth, 2015
B
BeiGene
Biotech · Growth, 2014
L
Legend Biotech
Biotech · Growth, 2014
Z
Zai Lab
Biotech · Growth, 2014
H
Hansoh Pharmaceutical
Biotech · Growth, 2013
I
Innovent Biologics
Biotech · Growth, 2011
Frequently Asked Questions
Vivo Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Norwest Venture Partners
Palo Alto, United States · 693 deals
Venrock
Palo Alto, United States · 638 deals
Foundation Capital
Palo Alto, United States · 545 deals
CRV
Palo Alto, United States · 515 deals
True Ventures
Palo Alto, United States · 493 deals
Highland Capital Partners
Palo Alto, United States · 432 deals